Solos Endoscopy Inc (SNDY) 0.0003 $SNDY
Solos Endoscopy's MamoView(R) to Participate at the Dr. Susan Love Research Foundation Symposium on the Breast
ACCESSWIRE - Mon Nov 24, 9:56AM CST
BOSTON, MA / ACCESSWIRE / November 24, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that it has been invited to participate at the 8th International Dr. Susan Love Research Foundation Symposium on the Breast.
Solos Endoscopy's MamoView(R) Demonstrates Strong Growth Potential
ACCESSWIRE - Wed Nov 12, 9:29AM CST
BOSTON, MA / ACCESSWIRE / November 12, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, is pleased to announce that the company's MamoView(R) Breast Endoscopy System has shown strong growth over the past 18 months. Solos management has reported that MamoView(R) product sales has increased as a percentage of gross sales and in the past 18 months the company has received more than $300,000 in MamoView(R) orders from hospitals nationwide.
Solos Endoscopy Successfully Completes ISO Certification Annual Audit by TUV SUD America
ACCESSWIRE - Wed Oct 08, 9:58AM CDT
BOSTON, MA / ACCESSWIRE / October 8, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the country, is pleased to announce that the company has successfully completed the annual audit for its ISO 13485:2003 Certification from TUV SUD America. The Certification to ISO 13485:2003 allows Solos Endoscopy to place the CE Mark on the majority of the company's endoscopic instruments including the MammoView(R) devices.
Solos Endoscopy Files for Medical Device License to Distribute its Endoscopic Instruments in Canada
ACCESSWIRE - Tue Sep 16, 9:42AM CDT
BOSTON, MA / ACCESSWIRE / September 16, 2014 / Solos Endoscopy, Inc. (OTC PINK: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that the company has completed its filing for the Canadian Medical Device License, which will allow Solos to sell certain endoscopic instruments, including the MammoView(R) devices, in Canada.
Solos Endoscopy Reports Financial Results for Period Ended June 30, 2014
ACCESSWIRE - Mon Aug 18, 11:00AM CDT
BOSTON, MA / ACCESSWIRE / August 18, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the United States, reported sales and earnings results for period ended June 30, 2014, and its quarterly disclosure statement on OTC Markets.com.
Solos Endoscopy Posts Shareholder Update on OTC Markets.com
ACCESSWIRE - Wed Jul 23, 9:23AM CDT
BOSTON, MA / ACCESSWIRE / July 23, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the Country, posted an update for the shareholders on OTC Markets.com.
Halozyme Announces Positive Opinion From CHMP For European Approval Of Roche's MabThera SC
PR Newswire - Fri Jan 24, 10:32AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that the EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve Roche's subcutaneous (SC) formulation of MabThera® (rituximab) using Halozyme's recombinant human hyaluronidase (rHuPH20) for the treatment of patients with common forms of non-Hodgkin lymphoma (NHL).
HALO: 9.34 (+0.31)
Pain Therapeutics - Drugs, Markets and Companies
PR Newswire - Thu Jan 16, 1:00PM CST
Dublin - Research and Markets (http://www.researchandmarkets.com/research/sqmftt/pain_therapeutics) has announced the addition of a new report "Pain Therapeutics - Drugs, Markets and Companies" to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
PTIE: 2.01 (-0.02)
Solos Endoscopy's MamoView(R) to Participate at the Dr. Susan Love Research Foundation Symposium on the Breast
ACCESSWIRE - Mon Nov 24, 9:56AM CST
BOSTON, MA / ACCESSWIRE / November 24, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that it has been invited to participate at the 8th International Dr. Susan Love Research Foundation Symposium on the Breast.
Solos Endoscopy's MamoView(R) Demonstrates Strong Growth Potential
ACCESSWIRE - Wed Nov 12, 9:29AM CST
BOSTON, MA / ACCESSWIRE / November 12, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, is pleased to announce that the company's MamoView(R) Breast Endoscopy System has shown strong growth over the past 18 months. Solos management has reported that MamoView(R) product sales has increased as a percentage of gross sales and in the past 18 months the company has received more than $300,000 in MamoView(R) orders from hospitals nationwide.
Solos Endoscopy Successfully Completes ISO Certification Annual Audit by TUV SUD America
ACCESSWIRE - Wed Oct 08, 9:58AM CDT
BOSTON, MA / ACCESSWIRE / October 8, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the country, is pleased to announce that the company has successfully completed the annual audit for its ISO 13485:2003 Certification from TUV SUD America. The Certification to ISO 13485:2003 allows Solos Endoscopy to place the CE Mark on the majority of the company's endoscopic instruments including the MammoView(R) devices.
Solos Endoscopy Files for Medical Device License to Distribute its Endoscopic Instruments in Canada
ACCESSWIRE - Tue Sep 16, 9:42AM CDT
BOSTON, MA / ACCESSWIRE / September 16, 2014 / Solos Endoscopy, Inc. (OTC PINK: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that the company has completed its filing for the Canadian Medical Device License, which will allow Solos to sell certain endoscopic instruments, including the MammoView(R) devices, in Canada.
Solos Endoscopy Reports Financial Results for Period Ended June 30, 2014
ACCESSWIRE - Mon Aug 18, 11:00AM CDT
BOSTON, MA / ACCESSWIRE / August 18, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the United States, reported sales and earnings results for period ended June 30, 2014, and its quarterly disclosure statement on OTC Markets.com.
Solos Endoscopy Posts Shareholder Update on OTC Markets.com
ACCESSWIRE - Wed Jul 23, 9:23AM CDT
BOSTON, MA / ACCESSWIRE / July 23, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the Country, posted an update for the shareholders on OTC Markets.com.
Halozyme Announces Positive Opinion From CHMP For European Approval Of Roche's MabThera SC
PR Newswire - Fri Jan 24, 10:32AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that the EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve Roche's subcutaneous (SC) formulation of MabThera® (rituximab) using Halozyme's recombinant human hyaluronidase (rHuPH20) for the treatment of patients with common forms of non-Hodgkin lymphoma (NHL).
HALO: 9.34 (+0.31)
Pain Therapeutics - Drugs, Markets and Companies
PR Newswire - Thu Jan 16, 1:00PM CST
Dublin - Research and Markets (http://www.researchandmarkets.com/research/sqmftt/pain_therapeutics) has announced the addition of a new report "Pain Therapeutics - Drugs, Markets and Companies" to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
PTIE: 2.01 (-0.02)
